Literature DB >> 30806444

Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.

Natasha Silva Constancio1,2, Maria Lucia Gomes Ferraz3,4, Carmen Tzanno Branco Martins2, Angiolina Campos Kraychete2, Paulo Lisboa Bitencourt4, Marcelo Mazza do Nascimento5,2.   

Abstract

According to data from the last census of the Brazilian Society of Nephrology (SBN), the prevalence of hepatitis C virus (HCV) in Brazilian hemodialysis units (HU) is 3.3%, about three times higher than what is reported for the Brazilian general population. Often, professionals working in HU are faced with clinical situations that require rapid HCV diagnosis in order to avoid horizontal transmission within the units. On the other hand, thanks to the development of new antiviral drugs, the cure of patients with HCV, both in the general population and in patients with chronic kidney disease and the disease eradication, appear to be very feasible objectives to be achieved in the near future . In this scenario, SBN and the Brazilian Society of Hepatology present in this review article a proposal to approach HCV within HUs.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30806444      PMCID： PMC6979573          DOI： 10.1590/2175-8239-JBN-2018-0177

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN： 0101-2800


  49 in total

1.  Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group.

Authors:  M Jadoul; C Cornu; C van Ypersele de Strihou
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

Review 2.  Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies.

Authors:  Fabrizio Fabrizi; Alessandra Penatti; Piergiorgio Messa; Paul Martin
Journal:  J Med Virol       Date:  2014-03-07       Impact factor: 2.327

3.  Brazilian Chronic Dialysis Survey 2016.

Authors:  Ricardo Cintra Sesso; Antonio Alberto Lopes; Fernando Saldanha Thomé; Jocemir Ronaldo Lugon; Carmen Tzanno Martins
Journal:  J Bras Nefrol       Date:  2017 Jul-Sep

4.  Treatment Choices for Hepatitis C in Patients with Kidney Disease.

Authors:  Fabrizio Fabrizi; Piergiorgio Messa
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-09       Impact factor: 8.237

5.  Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.

Authors:  F Fabrizi; V Dixit; P Messa; P Martin
Journal:  J Viral Hepat       Date:  2014-07-16       Impact factor: 3.728

6.  Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit.

Authors:  Emmanuelle Girou; Stéphane Chevaliez; Dominique Challine; Michaël Thiessart; Yoann Morice; Philippe Lesprit; Latifa Tkoub-Scheirlinck; Sophan Soing-Altrach; Florence Cizeau; Celine Cavin; Martine André; Djamel Dahmanne; Philippe Lang; Jean-Michel Pawlotsky
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

Review 7.  Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.

Authors:  Tao Li; Yundong Qu; Ying Guo; Yan Wang; Lei Wang
Journal:  Liver Int       Date:  2017-01-02       Impact factor: 5.828

8.  Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Authors:  Paul J Pockros; K Rajender Reddy; Parvez S Mantry; Eric Cohen; Michael Bennett; Mark S Sulkowski; David E Bernstein; Daniel E Cohen; Nancy S Shulman; Deli Wang; Amit Khatri; Manal Abunimeh; Thomas Podsadecki; Eric Lawitz
Journal:  Gastroenterology       Date:  2016-03-11       Impact factor: 22.682

Review 9.  Viral hepatitis in hemodialysis: An update.

Authors:  Bassam Bernieh
Journal:  J Transl Int Med       Date:  2015-09-30

10.  Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

Authors:  David Roth; David R Nelson; Annette Bruchfeld; AnnMarie Liapakis; Marcelo Silva; Howard Monsour; Paul Martin; Stanislas Pol; Maria-Carlota Londoño; Tarek Hassanein; Philippe J Zamor; Eli Zuckerman; Shuyan Wan; Beth Jackson; Bach-Yen Nguyen; Michael Robertson; Eliav Barr; Janice Wahl; Wayne Greaves
Journal:  Lancet       Date:  2015-10-05       Impact factor: 202.731
View more
  2 in total

1.  Brazilian dialysis survey 2019.

Authors:  Precil Diego Miranda de Menezes Neves; Ricardo de Castro Cintra Sesso; Fernando Saldanha Thomé; Jocemir Ronaldo Lugon; Marcelo Mazza Nascimento
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

2.  Brazilian Dialysis Census: analysis of data from the 2009-2018 decade.

Authors:  Precil Diego Miranda de Menezes Neves; Ricardo de Castro Cintra Sesso; Fernando Saldanha Thomé; Jocemir Ronaldo Lugon; Marcelo Mazza Nasicmento
Journal:  J Bras Nefrol       Date:  2020-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.